(Q46514154)
Statements
Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia (English)
Haralampos J Milionis
Konstantinos G Lagos
Alexandros D Tselepis